Background

Propolis, a resinous compound rich in polyphenols, flavonoids, and aromatic acids, has emerged as a prototypical nutritional immunomodulator that integrates antioxidant, anti-inflammatory, and metabolic regulatory pathways into a unified biological framework.

Rather than functioning as a simple antimicrobial or anti-inflammatory substance, propolis exerts multi-axis nutripharmacological control - restoring redox balance, immune precision, and metabolic flexibility across organ systems.

This review delineates the antioxidant–anti-inflammatory–immune-regulatory tri-axis as the mechanistic foundation of propolis’s systemic actions, and further synthesizes its disease-specific intervention evidence across cardiovascular–metabolic, infectious, hepatic–gastrointestinal, neurodegenerative, and dermatological domains.

Mechanistic Framework: The Nutritional Pharmacology Tri-Axis

1. Antioxidant Axis

Through the activation of the Nrf2/ARE signaling cascade, propolis enhances endogenous defense systems including heme oxygenase-1 (HO-1), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px).

Major phenolic components such as caffeic acid phenethyl ester (CAPE), quercetin, and artepillin C directly scavenge reactive oxygen species (ROS), stabilize mitochondrial membrane potential, and sustain NADPH/GSH recycling.

This axis constitutes the first layer of protection against oxidative injury, energy imbalance, and lipid peroxidation that underlie cardiovascular and metabolic pathologies.

2. Anti-Inflammatory Axis

Propolis suppresses excessive cytokine release by inhibiting the NF-κB and MAPK cascades, downregulating COX-2 and iNOS expression, and preventing NLRP3 inflammasome assembly.

The CAPE-induced upregulation of HO-1 and biliverdin acts as a feedback suppressor of the IKK complex, further attenuating inflammatory transcription.

These pathways dismantle the self-reinforcing oxidative–inflammatory loop responsible for chronic inflammatory and degenerative diseases.

3. Immune-Regulatory Axis

Beyond suppression, propolis fine-tunes immune homeostasis through bidirectional modulation: enhancing macrophage phagocytosis and NK cell activity under immunodeficiency, while restoring Treg/Th17 and Th1/Th2 balance under hyper-inflammatory conditions.

Its regulation of the AMPK–SIRT1–PGC-1α axis ensures metabolic support for immune tolerance, preventing exhaustion and sustaining antigen-specific memory.

This tri-axis coupling of signaling, metabolism, and functional immunity defines propolis as a systemic immune–metabolic synchronizer rather than a conventional pharmacologic suppressant.

Disease-Specific Nutritional Intervention Mechanisms

1. Cardiovascular–Metabolic Disorders

In atherosclerosis, metabolic syndrome, Type II Diabetes Mellitus, and non-alcoholic fatty liver disease, propolis attenuates endothelial oxidative stress, lipid peroxidation, and macrophage-driven inflammation.

By disrupting the ROS–TXNIP–NLRP3 axis and restoring mitochondrial biogenesis through AMPK–PGC-1α activation, it improves endothelial nitric oxide bioavailability, enhances fatty acid oxidation, and mitigates insulin resistance.

Clinical and preclinical findings reveal improved lipid profiles, decreased hepatic steatosis, and reversal of low-grade systemic inflammation, confirming propolis’s role as a nutritionally driven modulator of cardio-metabolic homeostasis.

2. Infectious and Post-Infectious Conditions

Propolis demonstrates dual-phase efficacy in upper respiratory tract infections, influenza, viral pharyngitis, and oral–periodontal inflammation.

Its polyphenolic constituents block viral entry by downregulating ACE2 and TMPRSS2 expression and inhibit viral RNA polymerase activity.

Simultaneously, propolis attenuates cytokine storm responses by lowering IL-6, IL-1β, and TNF-α production, while accelerating resolution through M2 macrophage and Treg activation.

Clinically, this results in shorter disease duration, reduced recurrence, and enhanced mucosal recovery.

The synergy between propolis and micronutrients such as vitamin C, zinc, and probiotics further strengthens mucosal immunity and epithelial defense, establishing its role in functional nutritional immunotherapy for infectious diseases.

3. Hepatic and Gastrointestinal Disorders

In chronic hepatitis, NAFLD, and inflammatory bowel disease, propolis reduces lipid peroxidation products (MDA, 4-HNE), preserves glutathione redox cycling, and suppresses COX-2/iNOS overexpression.

Through Nrf2 and Treg activation, it restores epithelial barrier integrity and suppresses Th17-driven inflammation, effectively protecting hepatocytes and intestinal mucosa from oxidative and inflammatory injury.

4. Neurodegenerative and Neuro-inflammatory Disorders

The neuroprotective actions of propolis stem from its ability to modulate microglial polarization, suppress NLRP3 inflammasome activation, and sustain mitochondrial function.

By reducing ROS accumulation and JNK phosphorylation, it prevents neuronal apoptosis and synaptic degradation.

These findings underscore its potential in delaying the progression of neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases, where chronic neuro-inflammation and redox imbalance play central roles.

5. Dermatological and Barrier Disorders

In gingivitis, oral ulcers, eczema, dermatitis, and chronic wounds, propolis exhibits coordinated antimicrobial, anti-inflammatory, and reparative properties.

It disrupts bacterial biofilm formation, suppresses TLR4–NF-κB signaling, and enhances keratinocyte proliferation, collagen I/III synthesis, and angiogenesis.

In diabetic or delayed-healing wounds, it accelerates epithelial closure and tissue remodeling, validating its use as a topical and systemic nutritional repair modulator within the oral–skin–barrier axis.

Systemic Integration and Clinical Significance

Across these disease contexts, propolis orchestrates a consistent pattern of multi-level regulation:

• Redox normalization through Nrf2/ARE activation and ROS clearance;
• Inflammatory restraint via NF-κB/NLRP3 suppression and cytokine modulation; and
• Immune recalibration through Treg/Th17 and metabolic rebalancing.

These processes converge into a physiological triad of defense, resolution, and regeneration.

Unlike pharmacological suppressants, propolis preserves reversibility, adaptability, and safety under chronic use, enabling long-term nutritional management of oxidative-inflammatory-immune dysfunction.

It thus represents a cornerstone prototype for the field of Functional Nutritional Immunotherapy, bridging micronutrient signaling, cellular metabolism, and tissue homeostasis into an integrative therapeutic paradigm.